Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fludarabine-based Conditioning for Allogeneic Marrow Transplantation From HLA-compatible Unrelated Donors in Severe Aplastic Anemia (BMT CTN #0301)

NCT00326417 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT00326417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00326417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fludarabine-based Conditioning for Allogeneic Marrow Transplantation From HLA-compatible Unrelated Donors in Severe Aplastic Anemia (BMT CTN #0301)
Lead sponsor
Medical College of Wisconsin
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2006
Completion date
January 31, 2016
Enrollment
97 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, aplastic